IRISH PHARMACY JOURNAL Official Journal of the Pharmaceutical Society of Ireland

IRISH PHARMACY JOURNAL Official Journal of the Pharmaceutical Society of Ireland

IRISH PHARMACY JOURNAL Official Journal of the Pharmaceutical Society of Ireland Index - Volume 85 January to December, 2007 Compiled by Carol Keogh The Pharmaceutical Society of Ireland, 18 Shrewsbury Road, Ballsbridge, Dublin 4, Republic of Ireland IRISH PHARMACY JOURNAL INDEX TO VOLUME 85 Page numbers Issue 1 – 40 January ‘07 R eaders should note that signed articles are indexed under two entries – the name of the contributor and the 41- 84 February ‘07 subject of the article. All references to “Society” refer to the Pharmaceutical Society of Ireland. All references to 85 - 128 March ‘07 “Council” refer to the Council of the Pharmaceutical Society of Ireland. Cross-references are listed in soft brackets 129 - 180 April ‘07 following each entry. Hard brackets indicate parentheses in a title. 181 - 220 May ‘07 ABBREVIATIONS: The following abbreviations are used in the index: 221 - 264 June ‘07 265 - 328 July ‘07 ADR Adverse Drug Reactions MHRA Medicines and Healthcare Regulatory Agency (UK) ADVANCE Action in Diabetes and Vascular Disease: perindopril/ MMR Measles, Mumps and Rubella 329 - 376 Aug/Sept ‘07 indapamide and Diamicron MR Controlled Evacuation MRII Medical Representatives’ Institute of Ireland 377 - 416 October ‘07 AED Automated External Defibrillator MRSA methicillin -resistant Staphylococcus aureus 417 - 460 November ‘07 AGM Annual General Meeting NAPHT National Association of Hospital Pharmacy Technicians NCPE National Centre for Pharmacoeconomics CHMP Committee for Human Medicinal Products 461 - 500 Dec ‘07/Jan ‘08 NHS National Health Service COPD Chronic Obstructive Pulmonary Disease DIT Dublin Institute of Technology OAB Overactive bladder EC European Commission OHLSC Our Lady’s Hospital for Sick Children EMCDDA European Monitoring Centre for Drugs & Drug Addiction OTC Office of Tobacco Control EMEA European Medicines Agency OTC Over the Counter EU European Union PCDS Primary Care Dermatology Society FDA Food & Drug Administration (US) PREVAIL Prevention of VTE after Acute Ischaemic Stroke with FIP Federation Internationale des Pharmaceutiques LMWH Enoxaparin RA Rheumatoid Arthritis FSAI Food Safety Authority of Ireland HIQA Health Information and Quality Authority PSI Pharmaceutical Society of Ireland HPAI Hospital Pharmacists’ Association of Ireland R&D Research and Development HSE Health Service Executive RCSI Royal College of Surgeons in Ireland HSP Health Support Programme RFID Radio Frequency Identification IHF Irish Heart Foundation RPSGB Royal Pharmaceutical Society of Great Britain IMB Irish Medicines Board SOPs Standard Operating Procedures IPA Irish Patients’ Association TB Tuberculosis IPHA Irish Pharmaceutical Healthcare Association TCD Trinity College Dublin TCM Traditional Chinese Medicine PMII Pharmaceutical Managers’ Institute of Ireland POM Prescription-only medicine UCC University College Cork MCQs Multiple Choice Questions UK United Kingdom A Arthritis Betaferon® Orencia® (abatacept) - treatment for RA Biopharmaceuticals – the new weapon of choice Adalimumab (Orencia) 371 in the battle against disease CHMP give Humira® (adalimumab) positive Aseptic Compounding (Collins, R.) 166-169 opinion for the treatment of Crohn’s Disease Designing a capacity plan for the Aseptic The Science behind Biopharmaceuticals (CHMP/Crohn’s Disease) 238 Compounding Unit in St. James’s Hospital (Cryan, S.A./Moran, P.J.) 202-204 Addiction (Capacity Planning/Hospital Pharmacy Issue/ Blood Pressure Suboxone® (buprenorphine/naloxone) – a new O’Boyle, N./St. James’s Hospital) 303-306 Impact of a community pharmacy-directed weight alternative to methadone (Buprenorphine/ Astellas European Foundation support TCD management programme on blood pressure Methadone) 124 School of Pharmacy research (R&D/ findings (Obesity/O’Brien, C./ Young Scientist Project [2007] – Codeine Schools) 102 Weight Management) 240-246 Addiction in Ireland (Codeine) 102 Asthma Trial shows benefits of blood pressure lowering ADR (see also Adverse Drug Reactions) Facts about asthma in Ireland 286 treatment for over-80s (Clinical Trial) 494 IMB launches new website with online ADR Singulair now available for children aged 2-14 Blood Tests reporting (IMB) 432 years with mild persistent Asthma Reflotron Plus – on the spot blood test results ADVANCE study shows benefits of perindopril/ (Paediatrics/Singulair) 36, 81 (Point of Care/Reflotron Plus) 321 indapamide (Perindopril) 454 Audit Committee Bonviva® studies show significant benefit in Adverse Drug Reactions and the role of the Fostering the principles of good governance reducing risk of non-vertebral fractures Pharmacist – Hepatotoxicity (Henman, M./ (Interview/MacHale, S.) 477-478 (Osteoporosis) 192 Hepatotoxicity/Pharmacovigilance) 436-442 Avastin Book Reviews Advertising (of medicines) Avastin – further indication approved 192 Antimicrobial Pharmacodynamics in Theory and For better or for worse – medicine advertising and Avastin – further positive results as a co-treatment Clinical Practice (2nd Edition) Nightingale, C., medicine use (Zephyr) 82 for lung and renal cancers (Cancer) 234 Ambrose, P. et al 449 AED’s Awards Applications of LC-MS in Toxicology Prevention of Sudden Cardiac Death – the role of Cork-based pharmacist wins top accolade 12-13 Polettini, A. {Ed.} 118 the Community Pharmacy (Cardiac/ Inaugural IPOS Pharmacy Excellence Awards Concise Clinical Pharmacology Greenstein, B. & Eggers, S.) 247 -250 (IPOS) 17 Greenstein, A. 172 Alcohol and Pregnancy (Pregnancy) 386 International Award for Mater Hospital Dietary Supplements (3rd Edition) Mason, P. 366 Allergy Pharmacist (Mater Misericordiae Hospital) 338 Drug-Induced Diseases – Prevention, Detection Cow’s Milk Allergy in Infants (Paediatrics) 325 La Roche-Posay International award for Alan and Management Tisdale, J.E., Mille, D.A. 118 GRAZAX® - positive second year results Irvine (OLHSC) 21 Endotoxins: Pyrogens, LAL Testing and (GRAZAX®) 110 Pharmaceutical Manufacturing Technology Depyrogenation Williams, K.L. {Ed.} 368 Analgesics Awards Ceremony [TCD] (Schools) 170 Handbook of Poisonous & Injurious Plants (2nd Guidance on OTC Analgesia in Pain Practice of Pharmacy Committee: Announcement Edition) Nelson, L.S., Shih, R.D., Management Launched (OTC/Pain) 152 of Funding Awards for Practice Based Balick, M.J. 212 Versatis® - Lidocaine -medicated plaster approved Research (Practice of Pharmacy) 90-92 Irish Medicines Formulary (2nd Edition) by MHRA (Lidocaine/Versatis) 80 Cock-Wall, A. 408 Anastrozole Managing Anticoagulant Patients in the Hospital Long-term safety data for Arimidex™ Battaglia, D. {Ed.} 406 [anastrozole] reinforce patient benefits B The Maudsley Prescribing Guidelines (9th Edition) (Cancer) 66 Taylor, D., Paton, C., Kerwin, R. {Eds.} 368 Antibiotics Baggot, J. MCQs in Clinical Pharmacy Azzopardi, L.M. GPs admit over-prescribing antibiotics (Over- International Suicide Prevention Conference 226 {Ed.} 319 nd prescribing) 428 Suicide prevention: what can we do – as people, Neutraceuticals (2 Edition) Lockwood, B. 366 Appointments as pharmacists? (Suicide) 400-402 Palliative Care: Core Skills and Clinical HIQA Director of Health Technology Assessment Bar coding (see Technology) Competencies Emanuel, L.L., Librach, S.L. (HIQA) 340 BD Diagnostics {Eds.} 449 Irish Pharmaceutical Healthcare Association BD’s MRSA test gets EU approval (MRSA) 238 Patient Compliance with Medications: Issues and (IPHA) 340 Benevolent Fund Opportunities Fincham, J.E. {Ed.} 450 New member of IPHA appointed to the Board of Benevolent Fund AGM 386 Pharmacy and the US healthcare System (3rd Directors (IPHA) 257 Benevolent Fund Golf Classic, 2007 282 Edition) Smith, M.I., Wertheimer, A.I., Pfizer appoints new Country Manager Benevolent Fund: let them know they’re not Fincham, J.E. {Eds.} 32 (Pfizer) 256 forgotten (Dowd, M./Interview) 451-452 Psoriasis – at your fingertips Mitchell, T., Arimidex™ (see Anastrozole) Penzer, R. 212 Rules & Guidance for Pharmaceutical Chronic Pain (see Pain) Cramp Distributors 2007 Pharmaceutical Press 366 Clarymist - New Dry Eye spray treatment Botox effective at relieving writer’s cramp Rules and Guidance for Pharmaceutical (Eyes) 79 (Botox) 66 Manufacturers and Distributors 2007 Clinical Trial/Research Results Crawford, A.M. Supplier errors in deliveries to (Orange Guide) Pharmaceutical Press 172 Trial shows benefits of blood pressure lowering the pharmacy of a large Dublin teaching hospital Stockley’s Drug Interactions 2007 Pocket treatment for over-80s (Blood Pressure) 494 (Hammond, E./Hospital Pharmacy Issue/ Companion Pharmaceutical Press 246 Clonmel Healthcare Supplier Errors) 302 Successfully Marketing Clinical Trial Results: Clonmel Healthcare’s new corporate identity 105 Creaton, G. Winning in the Healthcare Business Clonmel rebrands its consumer division – A Collaborative Study of Medication Umbach, G. 408 ClonMedica 276 Safety in Four Irish hospitals (Colohan, G./ Textbook of Pharmacoepidemiology Storm, B., Codeine Delaney, T./Harnett, B./Inter-Hospital Study/ Kimmel, S.E. {Eds.} 318-319 Young Scientist Project (2007) – Codeine Kirke, C./Medication Safety/Peer Review/ The Complete Guide to Medical Writing Addiction in Ireland (Addiction) 102 Tighe, P.) 68-73 Stuart, M.C. {Ed.} 318 Colds (see Cough) Pain control in post-operative patients Boots Collins, R. Biopharmaceuticals – the new weapon (Murphy, P.G.M./Pain) 353-356 Reckitt Benckiser acquisition of Boots Healthcare of choice in the battle against disease Crohn’s Disease International (Reckitt Benckiser) 21 (Biopharmaceuticals) 166-169 CHMP give Humira® (adalimumab)

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    11 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us